Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article matching "lysine methylation"

GrantNIH REPORTERMay 11

New NIH Grant: Lysine Methylation as a Novel Regulatory Mechanism of HPV E2 Function — $209K at Unknown Institution

Scientists are studying how a virus called HPV (human papillomavirus) uses a process called lysine methylation to survive in human cells. HPV can cause several types of cancer, including cervical cancer. This research aims to understand how the virus works so doctors can develop better treatments to stop HPV infections before they turn into cancer.

WHY IT MATTERSThis basic research could eventually lead to new non-invasive treatments for high-risk HPV infections, which currently have no effective alternatives to invasive procedures and surgery.
Good to knowCervical cancerOropharyngeal cancerAnogenital cancer

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases